Cargando…
Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer
Obesity increases the risk of colorectal cancer (CRC) by 30%. The obese tumor microenvironment compromises antitumor immunity by eliciting exhausted T cells (Tex). Hypothesizing that Dahuang Fuzi Baijiang decoction (DFB) is a combined classical prescription from the “Synopsis of Prescriptions of the...
Autores principales: | Xu, Yihua, Wang, Hao, Wang, Tao, Chen, Chunhui, Sun, Ruibo, Yao, Wanyu, Ma, Ye, Zhang, Qingyuan, Wu, Liyi, Zeng, Shanmei, Sun, Xuegang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128181/ https://www.ncbi.nlm.nih.gov/pubmed/35238098 http://dx.doi.org/10.1111/cas.15311 |
Ejemplares similares
-
The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction
por: Guo, Jun-feng, et al.
Publicado: (2022) -
Dahuang Fuzi Decoction Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in Chronic Aristolochic Acid Nephropathy
por: Shui, Guang-xing, et al.
Publicado: (2017) -
Yiyi Fuzi Baijiang Decoction Alleviates Ulcerative Colitis Partly by Regulating TLR4-Mediated PI3K/Akt and NF-κB Pathways
por: Chen, Liping, et al.
Publicado: (2022) -
Identification of the effect and mechanism of Yiyi Fuzi Baijiang powder against colorectal cancer using network pharmacology and experimental validation
por: Xiang, Bin, et al.
Publicado: (2022) -
Treatment of Modified Dahuang Fuzi Decoction on Cognitive Impairment Induced by Chronic Kidney Disease through Regulating AhR/NF-κB/JNK Signal Pathway
por: Gu, Mingjia, et al.
Publicado: (2022)